Summary
To define the kinetics of chylomicron apolipoprotein-B catabolism in diabetic subjects with lipaemia, autologous chylomicrons (Sf 400) harvested from plasma following an oral fat load were radioiodinated and re-injected. The radioactivity in the tetramethylurea-insoluble, non-lipid Sf>400 lipoprotein fraction was followed in serial samples over 60–72h on a fat-free, isocaloric diet in: (1) five normal subjects; (2) four hypertriglyceridaemic, non-diabetic subjects; and (3) five diabetic patients (one subject, No. 3, was studied twice). The plasma apolipoprotein-B decay curve for the Sf 400 fraction disclosed biphasic disappearance: a rapid first phase (residence time 0.8–1.9 h) accounting for the large majority of removal (60%–95%) and a slower second phase (residence time 3.6–47.6 h), accounting for the remainder. Total chylomicron apolipoprotein-B residence times were similar in normolipidaemic (1.8–7.3 h) and hypertriglyceridaemic (2.3–10.3 h) non-diabetic subjects and the mildly hypertriglyceridaemic diabetic patients (5.6 and 5.8 h). In the untreated lipaemic diabetic subjects (Nos. 1 and 2), only a single, much slower phase was observed (total chylomicron apolipoprotein-B residence time 38.5–58 h). Adipose tissue biopsy in one of these subjects (No. 1) disclosed profoundly low lipoprotein lipase activity. The lipaemic diabetic subject (No. 3) studied early during treatment showed an intermediate pattern. These studies suggest a key role for insulin-dependent, lipoprotein lipase-mediated triglyceride hydrolysis in the removal of chylomicrons from plasma.
Article PDF
Similar content being viewed by others
References
Bagdade JD, Porte D Jr, Bierman EL (1967) Diabetic lipemia: a form of acquired fat-induced lipemia. New Engl J Med 276: 427–433
Chait A, Robertson HT, Brunzell JD (1981) Chylomicronemia syndrome in diabetes mellitus. Diabetes Care 4: 343–348
Pykalisto OJ, Smith PH, Brunzell JD (1975) Determinants of human adipose tissue lipoprotein lipase: effects of diabetes and obesity on basal and diet induced activity. J Clin Invest 56: 1108–1117
Brunzell JD, Porte D Jr, Bierman EL (1975) Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). Metabolism 24: 1123–1138
Brunzell JD, Hazzard WR, Porte D Jr, Bierman EL (1973) Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest 52: 1577–1585
Taskinen M-R, Nikkila EA (1979) Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Diabetologia 17: 351–356
Schaefer EJ, Jenkins LL, Brewer HB Jr (1978) Human chylomicron apolipoprotein metabolism. Biochem Biophys Res Comm 80: 405–412
Havel RJ, Kane JP, Pagnan A (1976) Metabolism of lipid and protein components of triglyceride-rich lipoproteins in rats and humans. In: Greten H (ed) Lipoprotein metabolism. Springer-Verlag, Berlin Heidelberg New York, pp 65–69
WHO Expert Committee on Diabetes Mellitus (1980) Second report. Technical Report Series 646, Geneva
Brunzell JD, Schrott HG, Motulsky AG, Bierman EL (1976) Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 313–320
McFarlane AS (1958) Efficient trace labelling of proteins with iodine. Nature (London) 182: 53–54
Bilheimer DW, Eisenberg S, Levy RI (1972) The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 260: 212–221
Kushwaha RS, Hazzard WR (1978) Catabolism of very low density lipoproteins in the rabbit: effect of changing composition and pool size. Biochim Biophys Acta 528:176–189
Kushwaha RS, Chait A, Hazzard WR (1982) Catabolism of very low density lipoproteins in subjects with broad-beta disease: comparison with type IV hyperlipoproteinemia. J Lab Clin Med 31: 43–51
Lipid Research Clinics Program (1974) Manual of Laboratory Operations, Washington, DC, US Government Printing Office, DHEW Publication No. 75–628
Kane JP (1973) A rapid electrophoretic technique for identification of subunit species of apoprotein in serum lipoproteins. Anal Biochem 53: 350–364
Phair RD, Hall M III, Bilheimer DW, Levy RI, Goebel RH, Berman M (1976) Modeling lipoprotein metabolism in man. In: Proceedings of the Summer Computer Simulation Conference, Washington, DC, July 1976. California Simulation Councils, San Diego, California, pp 486–492
Berman M, Weiss MF (1967) SAAM Manual. U.S. Public Health Service Publication no. 1703. U.S. Government Printing Office, Washhington, DC
Pecoraro RE, Graf RT, Halter JB, Beiter H, Porte D (1979) Comparison of a colorimetric assay of glycosylated hemoglobin with ion-exchange chromatography. Diabetes 28: 1120–1125
Weber K, Osborn M (1969) The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 244: 4406–4412
Malloy MJ, Kane JP, Hardman DA, Hamilton RL, Dalal KB (1981) Normotriglyceridemic abetalipoproteinemia: absence of the B-100 apolipoprotein. J Clin Invest 67:1441–1450
Grundy SM, Mok HYI (1976) Chylomicron clearance in normal and hyperlipidemic man. Metabolism 25: 1225–1239
Quarfordt SH, Boston F, Hilderman H (1971) Transfer of triglyceride between isolated human lipoproteins. Biochim Biophys Acta 231: 290–294
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haffner, S.M., Foster, D.M., Kushwaha, R.S. et al. Retarded chylomicron apolipoprotein-B catabolism in Type 2 (non-insulin-dependent) diabetic subjects with lipaemia. Diabetologia 26, 349–354 (1984). https://doi.org/10.1007/BF00266035
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00266035